Brain–Computer Interfaces - Index of

Brain–Computer Interfaces for Communication and Control in Locked-in Patients 199
References
1. M. Cudkowicz, M. Qureshi, and J. Shefner, Measures and markers in amyotrophic lateral
sclerosis. NeuroRx, 1(2), 273–283, (2004).
2. B.R. Brooks, Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin, 14(2), 399–
420, (1996).
3. H. Hayashi and E.A. Oppenheimer, ALS patients on TPPV: Totally locked-in state, neurologic
findings and ethical implications. Neurology, 61(1), 135–137, (2003).
4. N. Buchardi, O. Rauprich, and J. Vollmann, Patienten Selbstbestimmung und Patientenverfügungen
aus der Sicht von Patienten mit amyotropher Lateralsklerose: Eine qualitative
empirische Studie. Ethik der Medizin, 15, 7–21, (2004).
5. P.B. Bascom and S.W. Tolle, Responding to requests for physician-assisted suicide: These are
uncharted waters for both of us. JAMA, 288(1), 91–98, (2002).
6. F.J. Erbguth, Ethische und juristische Aspekte der intensicmedizinischen Behandlung bei
chronisch-progredienten neuromuskulären Erkrankungen. Intensivmedizin, 40, 464–657,
(2003).
7. A. Kübler, C. Weber and N. Birbaumer, Locked-in – freigegeben für den Tod. Wenn
nur Denken und Fühlen bleiben – Neuroethik des Eingeschlossenseins. Zeitschrift für
Medizinische Ethik, 52, 57–70, (2006).
8. G.D. Borasio, Discontinuing ventilation of patients with amyotrophic lateral sclerosis.
Medical, legal and ethical aspects. Medizinische Klinik, 91(2), 51–52, (1996).
9. C. Neudert, D. Oliver, M. Wasner, G.D. Borasio, The course of the terminal phase in patients
with amyotrophic lateral sclerosis. J Neurol, 248(7), 612–616, (2001).
10. A.H. Moss, Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and
patient, family, and physician attitudes. Neurology, 43(2), 438–443, (1993).
11. E.R. McDonald, S.A. Wiedenfield, A. Hillel, C.L. Carpenter, R.A. Walter, Survival in amyotrophic
lateral sclerosis. The role of psychological factors. Arch Neurol 51(1), 17–23,
(1994).
12. A. Kübler, S. Winters, A.C. Ludolph, M. Hautzinger, N. Birbaumer, Severity of depressive
symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil
Neural Repair, 19, 1–12, (2005).
13. Z. Simmons, B.A. Bremer, R.A. Robbins, S.M. Walsh, S. Fischer, Quality of life in ALS
depends on factors other than strength and physical function. Neurology, 55(3), 388–392,
(2000).
14. R.A. Robbins, Z. Simmons, B.A. Bremer, S.M. Walsh, S. Fischer, Quality of life in ALS is
maintained as physical function declines. Neurology, 56(4), 442–444, (2001).
15. A. Chio, G.A., Montuschi, A. Calvo, N. Di Vito, P. Ghiglione, R. Mutani, A cross sectional
study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatr, 75(11), 1597–
601, (2004).
16. A. Kurt, F. Nijboer, T. Matuz, A. Kübler, Depression and anxiety in individuals with amyotrophic
lateral sclerosis: epidemiology and management. CNS Drugs, 21(4), 279–291,
(2007).
17. A. Kübler, S. Winter, J. Kaiser, N. Birbaumer, M. Hautzinger, Das ALS-Depressionsinventar
(ADI): Ein Fragebogen zur Messung von Depression bei degenerativen neurologischen
Erkrankungen (amyotrophe Lateralsklerose). Zeit KL Psych Psychoth, 34(1), 19–26, (2005).
18. C. Paillisse, L. Lacomblez, M. Dib, G. Bensimon, S. Garcia-Acosta, V. Meininger, Prognostic
factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph
Lateral Scler Other Motor Neuron Disord, 6(1), 37–44, (2005).
19. A. Kubler, and N. Birbaumer (2008) Brain-computer interfaces and communication in paralysis:
Extinction of goal directed thinking in completely paralysed patients? Clin Neurophysiol,
119, 2658–2666.
20. J.D. Bauby, Le scaphandre et le papillon. Editions Robert Laffont, Paris, (1997).
21. N. Birbaumer, Breaking the silence: Brain-computer interfaces (BCI) for communication and
motor control. Psychophysiology, 43(6), 517–532, (2006).